+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Perfusion Systems - Global Strategic Business Report

  • PDF Icon

    Report

  • 131 Pages
  • May 2026
  • Region: Global
  • Market Glass, Inc.
  • ID: 4805856
The global market for Perfusion Systems was estimated at US$1.2 Billion in 2025 and is projected to reach US$1.6 Billion by 2032, growing at a CAGR of 4.4% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Perfusion Systems Market - Key Trends and Drivers Summarized

How Do Perfusion Systems Revolutionize Medical Procedures?

Perfusion systems play a crucial role in modern medical procedures by ensuring the effective delivery of oxygen and essential nutrients to tissues and organs during surgeries and other critical medical interventions. These systems are indispensable in cardiopulmonary bypass surgeries, organ transplantation, and various forms of intensive care. During open-heart surgery, for example, perfusion systems temporarily take over the function of the heart and lungs, maintaining blood circulation and oxygenation. This capability is vital for the success of complex surgical procedures and has significantly improved patient outcomes. Moreover, in organ transplantation, perfusion systems are used to preserve organs outside the body, extending the time available for transplantation and improving the viability of donor organs. The precision and reliability of perfusion systems have revolutionized the field of surgery and critical care, enabling more complex and life-saving procedures to be performed safely.

What Technological Innovations Are Shaping Perfusion Systems?

Technological innovations are at the forefront of advancements in perfusion systems, enhancing their efficiency, safety, and functionality. One notable development is the integration of advanced monitoring and control technologies, which allow for real-time assessment and adjustment of perfusion parameters. This ensures optimal perfusion conditions and reduces the risk of complications. Another significant innovation is the use of biocompatible materials and coatings in the construction of perfusion devices, which minimizes the risk of adverse reactions and enhances patient safety. Additionally, the advent of portable and minimally invasive perfusion systems has expanded their use beyond the operating room to include field hospitals and emergency settings. Advances in software and data analytics also enable more precise control and monitoring, improving outcomes in both surgical and non-surgical applications. These technological strides are making perfusion systems more versatile and effective, meeting the evolving needs of healthcare providers.

How Are Perfusion Systems Applied in Various Medical Fields?

Perfusion systems are applied across a broad spectrum of medical fields, each leveraging their capabilities to enhance patient care. In cardiovascular medicine, these systems are essential for procedures like coronary artery bypass grafting and valve replacement surgeries. In transplantation medicine, perfusion systems preserve and enhance the viability of organs such as kidneys, livers, and hearts, facilitating successful transplants and reducing waiting times. In oncology, perfusion systems are used in isolated limb perfusion techniques to deliver high doses of chemotherapy to specific areas, minimizing systemic side effects. Additionally, in critical care, extracorporeal membrane oxygenation (ECMO) is a life-saving application of perfusion technology, providing prolonged cardiac and respiratory support to patients with severe heart and lung conditions. The versatility and effectiveness of perfusion systems in these varied applications underscore their vital role in advancing medical treatment and patient outcomes.

What Factors Are Driving the Growth in the Perfusion Systems Market?

The growth in the perfusion systems market is driven by several factors. One of the primary drivers is the increasing prevalence of cardiovascular diseases and the rising demand for cardiac surgeries and interventions. The aging global population is also contributing to the market expansion, as older individuals are more likely to require surgeries that depend on perfusion systems. Technological advancements, such as the development of more sophisticated and portable perfusion devices, are further propelling market growth by expanding the range of applications and improving patient outcomes. Additionally, the growing emphasis on organ transplantation and the continuous improvement in organ preservation techniques are boosting the demand for perfusion systems. The expanding use of perfusion systems in emerging fields such as oncology and regenerative medicine is also a significant growth driver. As healthcare providers seek to enhance treatment efficacy and patient care, the demand for advanced perfusion systems is set to increase, ensuring robust market growth in the coming years.

Report Scope

The report analyzes the Perfusion Systems market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:
  • Segments: Application (Cardiopulmonary Perfusion System Application, Cell Perfusion System Application, Ex-Vivo Organ Perfusion System Application)
  • Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Cardiopulmonary Perfusion System Application segment, which is expected to reach US$737.4 Million by 2032 with a CAGR of a 4.5%. The Cell Perfusion System Application segment is also set to grow at 3.2% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $349.7 Million in 2025, and China, forecasted to grow at an impressive 4.4% CAGR to reach $288.7 Million by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Perfusion Systems Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Perfusion Systems Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Perfusion Systems Market expected to evolve by 2032?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2032?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as ALA Scientific Instruments, Inc., Getinge AB, Harvard Bioscience, Inc., Lifeline Scientific, Inc., LivaNova PLC and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the companies featured in this Perfusion Systems market report include:

  • ALA Scientific Instruments, Inc.
  • Getinge AB
  • Harvard Bioscience, Inc.
  • Lifeline Scientific, Inc.
  • LivaNova PLC
  • Medtronic PLC
  • Merck KgaA
  • Nipro Corporation
  • Repligen Corporation
  • Spectrum Laboratories, Inc.
  • Terumo Corporation
  • Xenios AG
  • XVIVO Perfusion AB

Domain Expert Insights

This market report incorporates insights from domain experts across enterprise, industry, academia, and government sectors. These insights are consolidated from multilingual multimedia sources, including text, voice, and image-based content, to provide comprehensive market intelligence and strategic perspectives. As part of this research study, the publisher tracks and analyzes insights from 1,903 domain experts. Clients may request access to the network of experts monitored for this report, along with the online expert insights tracker.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
  • How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind
  • Global Economic Update
  • Perfusion Systems - Global Key Competitors Percentage Market Share in 2026 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2026 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Advances in Organ Preservation Technologies Propel Growth in Perfusion Systems Market
  • Increasing Demand for Minimally Invasive Surgical Procedures Strengthens Business Case for Perfusion Systems
  • Technological Innovations in Perfusion Pumps Accelerate Market Adoption
  • Rising Prevalence of Cardiovascular Diseases Spurs Demand for Perfusion Systems
  • Expansion of Organ Transplantation Procedures Generates Market Opportunities
  • Growing Investments in Healthcare Infrastructure Sustain Market Growth
  • Adoption of Portable and Compact Perfusion Systems Expands Addressable Market
  • Increasing Focus on Patient Safety and Outcome Improves Demand for Advanced Perfusion Systems
  • Regulatory Approvals and Compliance Requirements Propel Market Growth
  • Development of Smart Perfusion Systems with Real-Time Monitoring Throws Spotlight on Technological Advancements
  • Rising Geriatric Population Drives Demand for Cardiac Perfusion Systems
  • Increasing Number of Critical Care Units Drives Adoption of Perfusion Systems
  • Strategic Collaborations and Partnerships in Healthcare Sector Strengthen Market Growth
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Perfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 2: World Historic Review for Perfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 3: World 13-Year Perspective for Perfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020, 2026 & 2032
  • Table 4: World Perfusion Systems Market Analysis of Annual Sales in US$ Thousand for Years 2020 through 2032
  • Table 5: World Recent Past, Current & Future Analysis for Cardiopulmonary Perfusion System Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 6: World Historic Review for Cardiopulmonary Perfusion System Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 7: World 13-Year Perspective for Cardiopulmonary Perfusion System Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 8: World Recent Past, Current & Future Analysis for Cell Perfusion System Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 9: World Historic Review for Cell Perfusion System Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 10: World 13-Year Perspective for Cell Perfusion System Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
  • Table 11: World Recent Past, Current & Future Analysis for Ex-Vivo Organ Perfusion System Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 12: World Historic Review for Ex-Vivo Organ Perfusion System Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 13: World 13-Year Perspective for Ex-Vivo Organ Perfusion System Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020, 2026 & 2032
III. MARKET ANALYSIS
UNITED STATES
  • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
  • Table 14: USA Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 15: USA Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 16: USA 13-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application for the Years 2020, 2026 & 2032
CANADA
  • Table 17: Canada Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 18: Canada Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 19: Canada 13-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application for the Years 2020, 2026 & 2032
JAPAN
  • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
  • Table 20: Japan Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 21: Japan Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 22: Japan 13-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application for the Years 2020, 2026 & 2032
CHINA
  • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
  • Table 23: China Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 24: China Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 25: China 13-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application for the Years 2020, 2026 & 2032
EUROPE
  • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
  • Table 26: Europe Recent Past, Current & Future Analysis for Perfusion Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2025 through 2032 and % CAGR
  • Table 27: Europe Historic Review for Perfusion Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 28: Europe 13-Year Perspective for Perfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020, 2026 & 2032
  • Table 29: Europe Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 30: Europe Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 31: Europe 13-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application for the Years 2020, 2026 & 2032
FRANCE
  • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
  • Table 32: France Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 33: France Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 34: France 13-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application for the Years 2020, 2026 & 2032
GERMANY
  • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
  • Table 35: Germany Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 36: Germany Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 37: Germany 13-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application for the Years 2020, 2026 & 2032
ITALY
  • Table 38: Italy Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 39: Italy Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 40: Italy 13-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application for the Years 2020, 2026 & 2032
UNITED KINGDOM
  • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
  • Table 41: UK Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 42: UK Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 43: UK 13-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application for the Years 2020, 2026 & 2032
REST OF EUROPE
  • Table 44: Rest of Europe Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 45: Rest of Europe Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 46: Rest of Europe 13-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application for the Years 2020, 2026 & 2032
ASIA-PACIFIC
  • Perfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
  • Table 47: Asia-Pacific Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 48: Asia-Pacific Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 49: Asia-Pacific 13-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application for the Years 2020, 2026 & 2032
REST OF WORLD
  • Table 50: Rest of World Recent Past, Current & Future Analysis for Perfusion Systems by Application - Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2025 through 2032 and % CAGR
  • Table 51: Rest of World Historic Review for Perfusion Systems by Application - Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2024 and % CAGR
  • Table 52: Rest of World 13-Year Perspective for Perfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiopulmonary Perfusion System Application, Cell Perfusion System Application and Ex-Vivo Organ Perfusion System Application for the Years 2020, 2026 & 2032
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ALA Scientific Instruments, Inc.
  • Getinge AB
  • Harvard Bioscience, Inc.
  • Lifeline Scientific, Inc.
  • LivaNova PLC
  • Medtronic PLC
  • Merck KgaA
  • Nipro Corporation
  • Repligen Corporation
  • Spectrum Laboratories, Inc.
  • Terumo Corporation
  • Xenios AG
  • XVIVO Perfusion AB

Table Information